Literature DB >> 11131974

Overview of vector design for mammalian gene expression.

R J Kaufman1.   

Abstract

The expression of cloned genes in mammalian cells is a basic tool for understanding gene expression, protein structure, and function, and biological regulatory mechanisms. The level of protein expression from heterologous genes introduced into mammalian cells depends upon multiple factors including DNA copy number, efficiency of transportation, mRNA processing, mRNA transport, mRNA stability, and translational efficiency, and protein processing, transport, and stability. Different genes exhibit different rate limiting steps for efficient expression. Multiple strategies are available to obtain high level expression in mammalian cells. This article reviews vector design for expression of foreign genes in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131974     DOI: 10.1385/MB:16:2:151

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  23 in total

1.  An auto-inducible vector conferring high glucocorticoid inducibility upon stable transformant cells.

Authors:  M S Ko; N Takahashi; N Sugiyama; T Takano
Journal:  Gene       Date:  1989-12-14       Impact factor: 3.688

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Overexpression of human TRK proto-oncogene into mouse cells using an inducible vector system.

Authors:  R Mulherkar; F Coulier
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

Review 4.  Control of gene expression at the level of translation initiation.

Authors:  R J Kaufman
Journal:  Curr Opin Biotechnol       Date:  1994-10       Impact factor: 9.740

5.  GFP in mammalian cells.

Authors:  J Pines
Journal:  Trends Genet       Date:  1995-08       Impact factor: 11.639

Review 6.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

7.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms.

Authors:  M V Davies; H W Chang; B L Jacobs; R J Kaufman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Inducible expression of human phospholipase C-gamma 2 and its activation by platelet-derived growth factor B-chain homodimer and platelet-derived growth factor A-chain homodimer in transfected NIH 3T3 fibroblasts.

Authors:  F Totzke; D Marmé; H Hug
Journal:  Eur J Biochem       Date:  1992-02-01

Review 10.  Vaccinia and other poxvirus expression vectors.

Authors:  B Moss
Journal:  Curr Opin Biotechnol       Date:  1992-10       Impact factor: 9.740

View more
  12 in total

1.  Expression of human proteins at the Southeast Collaboratory for Structural Genomics.

Authors:  Michael R Mayer; Tamara A Dailey; Clay M Baucom; Jill L Supernak; Michael C Grady; Harris E Hawk; Harry A Dailey
Journal:  J Struct Funct Genomics       Date:  2004

2.  Absolute quantitation of isoforms of post-translationally modified proteins in transgenic organism.

Authors:  Yaojun Li; Yiwei Shu; Changchao Peng; Lin Zhu; Guangyu Guo; Ning Li
Journal:  Mol Cell Proteomics       Date:  2012-03-22       Impact factor: 5.911

3.  Development of transfection and high-producer screening protocols for the CHOK1SV cell system.

Authors:  M Celina de la Cruz Edmonds; Melanie Tellers; Christine Chan; Peter Salmon; David K Robinson; Julia Markusen
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

4.  High-level transgene expression by homologous recombination-mediated gene transfer.

Authors:  Mélanie Grandjean; Pierre-Alain Girod; David Calabrese; Kaja Kostyrko; Marianne Wicht; Florence Yerly; Christian Mazza; Jacques S Beckmann; Danielle Martinet; Nicolas Mermod
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

5.  The bag or the spindle: the cell factory at the time of systems' biology.

Authors:  Antoine Danchin
Journal:  Microb Cell Fact       Date:  2004-11-10       Impact factor: 5.328

6.  Production of human papilloma virus type 16 e6 oncoprotein as a recombinant protein in eukaryotic cells.

Authors:  H Mirshahabi; H Soleimanjahi; Z Pourpak; Z Meshkat; Z M Hassan
Journal:  Iran J Cancer Prev       Date:  2012

7.  miR-206-3p Inhibits 3T3-L1 Cell Adipogenesis via the c-Met/PI3K/Akt Pathway.

Authors:  Renqiao Tang; Feifei Ma; Wei Li; Shengrong Ouyang; Zhuo Liu; Jianxin Wu
Journal:  Int J Mol Sci       Date:  2017-07-14       Impact factor: 5.923

8.  Expression of antibodies using single open reading frame (sORF) vector design: Demonstration of manufacturing feasibility.

Authors:  Wendy R Gion; Rachel A Davis-Taber; Dean A Regier; Emma Fung; Limary Medina; Ling C Santora; Sahana Bose; Alexander V Ivanov; Barbara A Perilli-Palmer; Chris M Chumsae; Joseph G Matuck; Yune Z Kunes; Gerald R Carson
Journal:  MAbs       Date:  2013-05-31       Impact factor: 5.857

9.  Establishment of stably transfected cells constitutively expressing the full-length and truncated antigenic proteins of two genetically distinct mink astroviruses.

Authors:  Mehdi R M Bidokhti; Karin Ullman; Trine H Jensen; Mariann Chriél; Amin Mottahedin; Muhammad Munir; Anna Maria Andersson; Olivier Detournay; Anne Sofie Hammer; Claudia Baule
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

10.  A Simple and Scalable Strategy for Analysis of Endogenous Protein Dynamics.

Authors:  Marie K Schwinn; Leta S Steffen; Kris Zimmerman; Keith V Wood; Thomas Machleidt
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.